Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret Past Earnings Performance
Past criteria checks 0/6
Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret's earnings have been declining at an average annual rate of -27.7%, while the Biotechs industry saw earnings growing at 12.5% annually. Revenues have been declining at an average rate of 39% per year. Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret's return on equity is 15.1%, and it has net margins of 74.9%.
Key information
-27.7%
Earnings growth rate
-39.4%
EPS growth rate
| Biotechs Industry Growth | 14.8% |
| Revenue growth rate | -39.0% |
| Return on equity | 15.1% |
| Net Margin | 74.9% |
| Last Earnings Update | 30 Sep 2023 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 23 | 164 | 123 | 131 | 5 |
| 30 Jun 23 | 161 | 172 | 115 | 3 |
| 31 Mar 23 | 171 | 179 | 99 | 3 |
| 31 Dec 22 | 269 | 330 | 85 | 3 |
| 30 Sep 22 | 360 | 526 | 68 | 2 |
| 30 Jun 22 | 396 | 534 | 59 | 1 |
| 31 Mar 22 | 437 | 521 | 49 | 1 |
| 31 Dec 21 | 410 | 433 | 42 | 1 |
| 31 Dec 20 | 422 | 293 | 21 | 1 |
Quality Earnings: ANGEN has a high level of non-cash earnings.
Growing Profit Margin: ANGEN's current net profit margins (74.9%) are lower than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ANGEN's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: ANGEN's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ANGEN had negative earnings growth (-76.7%) over the past year, making it difficult to compare to the Biotechs industry average (-2.9%).
Return on Equity
High ROE: ANGEN's Return on Equity (15.1%) is considered low.